Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children



Status:Completed
Conditions:Cosmetic, Dermatology, Dermatology, Hair Loss
Therapuetic Areas:Dermatology / Plastic Surgery
Healthy:No
Age Range:Any
Updated:11/18/2012
Start Date:June 2010
End Date:November 2012
Contact:Allergan Inc.
Email:clinicaltrials@allergan.com

Use our guide to learn which trials are right for you!


This study will evaluate the safety and efficacy of bimatoprost solution 0.03% once daily
application to the upper eyelid margins compared with vehicle in treating eyelash loss or
hypotrichosis (inadequate or not enough eyelashes) in children


Inclusion Criteria:

- Children who have inadequate eyelashes or have lost their eyelashes as a result of
chemotherapy treatment, who completed their chemotherapy (intensive treatment) at
least 4 weeks before starting the study, are considered to be at low risk for relapse
of their cancer, and are well enough to complete the study

- Children who have minimal to moderate inadequate eyelashes due to alopecia areata

- Adolescents between the ages of 15-17 years who have minimal to marked inadequate
eyelashes

Exclusion Criteria:

- Any eye disease or abnormality, eye surgery, permanent eyeliner, eyelash implants.

- Semi-permanent eyelash tint, dye or eyelash extension application within 3 months

- Use of over the counter eyelash growth products within 6 months.

- Use of prescription eyelash growth products (eg, Latisse®)

- Any eye condition that would prevent required ophthalmology exams
We found this trial at
1
site
?
mi
from
Santa Clara, CA
Click here to add this to my saved trials